blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2986617

EP2986617 - ANTI-BACTERIAL SIDEROPHORE-AMINOPENICILLIN CONJUGATES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.10.2020
Database last updated on 07.10.2024
FormerExamination is in progress
Status updated on  23.09.2019
Most recent event   Tooltip02.10.2020Application deemed to be withdrawnpublished on 04.11.2020  [2020/45]
Applicant(s)For all designated states
University of Notre Dame du Lac
940 Grace Hall
Notre Dame, Indiana 46556-5612 / US
[2016/08]
Inventor(s)01 / MILLER, Marvin, J.
17885 Tally Ho Drive
South Bend, IN 46635 / US
02 / JI, Cheng
316 E. 66th Street
Apt. 4b
New York, NY 10065 / US
03 / MILLER, Patricia, A.
17885 Tally Ho Drive
South Bend, IN 46635 / US
 [2016/08]
Representative(s)FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39 / IE
[N/P]
Former [2016/08]Hally, Anna-Louise
FRKelly
27 Clyde Road
Dublin 4 / IE
Application number, filing date13882608.623.10.2013
[2016/08]
WO2013US66408
Priority number, dateUS20131386580118.04.2013         Original published format: US201313865801
[2016/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014171971
Date:23.10.2014
Language:EN
[2014/43]
Type: A1 Application with search report 
No.:EP2986617
Date:24.02.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 23.10.2014 takes the place of the publication of the European patent application.
[2016/08]
Search report(s)International search report - published on:RU23.10.2014
(Supplementary) European search report - dispatched on:EP16.02.2017
ClassificationIPC:C07D499/21, C07D499/68, A61K31/43, A61P31/04, A61K38/12, A61K31/133, A61K31/165, A61K31/40, A61K31/405, A61K31/407, A61K31/4196, A61K31/42, A61K31/427, A61K31/439, A61K31/4409, A61K31/4439, A61K31/496, A61K31/545, A61K31/63, A61K31/635, A61K31/65
[2016/51]
CPC:
A61K31/235 (EP,US); A61K31/133 (EP,US); A61K31/165 (EP,US);
A61K31/167 (EP,US); A61K31/40 (EP,US); A61K31/405 (EP,US);
A61K31/407 (EP,US); A61K31/4196 (EP,US); A61K31/42 (EP,US);
A61K31/427 (EP,US); A61K31/43 (EP,US); A61K31/439 (EP,US);
A61K31/4409 (EP,US); A61K31/4439 (EP,US); A61K31/496 (EP,US);
A61K31/545 (EP,US); A61K31/63 (EP,US); A61K31/635 (EP,US);
A61K31/65 (EP,US); A61K31/702 (EP,US); A61K31/7024 (EP,US);
A61K31/7036 (EP,US); A61K31/704 (EP,US); A61K31/7048 (EP,US);
A61K31/7056 (EP,US); A61K47/547 (EP,US); A61P31/04 (EP);
Y02A50/30 (EP,US) (-)
Former IPC [2016/08]C07D499/21, C07D499/68, A61K31/43, A61P31/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/08]
TitleGerman:ANTIBAKTERIELLE SIDEROPHOR-AMINOPENICILLIN-KONJUGATE[2016/08]
English:ANTI-BACTERIAL SIDEROPHORE-AMINOPENICILLIN CONJUGATES[2016/08]
French:CONJUGUÉS SIDÉROPHORE-AMINOPÉNICILLINE ANTIBACTÉRIENS[2016/08]
Entry into regional phase20.10.2015National basic fee paid 
20.10.2015Search fee paid 
20.10.2015Designation fee(s) paid 
20.10.2015Examination fee paid 
Examination procedure20.10.2015Examination requested  [2016/08]
07.09.2017Amendment by applicant (claims and/or description)
26.09.2019Despatch of a communication from the examining division (Time limit: M06)
03.06.2020Application deemed to be withdrawn, date of legal effect  [2020/45]
26.06.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/45]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.09.2019
Fees paidRenewal fee
20.10.2015Renewal fee patent year 03
27.10.2016Renewal fee patent year 04
27.10.2017Renewal fee patent year 05
29.10.2018Renewal fee patent year 06
28.10.2019Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]  - CHENG JI ET AL, "Iron Transport-Mediated Drug Delivery: Practical Syntheses and In Vitro Antibacterial Studies of Tris-Catecholate Siderophore-Aminopenicillin Conjugates Reveals Selectively Potent Antipseudomonal Activity", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, US, (20120620), vol. 134, no. 24, doi:10.1021/ja303446w, ISSN 0002-7863, pages 9898 - 9901, XP055279967 [X] 1-15 * the whole document * [Y] 1-15

DOI:   http://dx.doi.org/10.1021/ja303446w
 [Y]  - B. LAYEUX ET AL, "Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, US, (20100907), vol. 54, no. 11, doi:10.1128/AAC.00441-10, ISSN 0066-4804, pages 4939 - 4941, XP055316946 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1128/AAC.00441-10
International search[A]US2004132707  (HEINISCH LOTHAR [DE], et al);
 [X]  - CHENG, JI ET AL., "Iron Transport-Mediated Drug Delivery: Practical Syntheses and In Vitro Antibacterial Studies of Tris-Catecholate SiderophoreConjugates Reveals Selectively Potent Antipseudomonal Activity.", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (20120604), vol. 134, no. 24, pages 9898 - 9901, XP055279967

DOI:   http://dx.doi.org/10.1021/ja303446w
 [A]  - MARTELL, ARTHUR E. ET AL., "Development of Iron Chelators for Cooley's Anemia.", INORGANICA CHIMICA ACTA, (1987), vol. 138, pages 215 - 230, XP000566129

DOI:   http://dx.doi.org/10.1016/S0020-1693(00)81225-6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.